The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In order to obtain representative data, all urologists who are members of the AFU may be invited to include their patients.
Patient being monitored for a non-muscle-invasive bladder tumor and having undergone a urinary test (biomarker) prior to their resection (biopsy) diagnosis or recurrence,
AND adult (equal to or > 18 years old),
AND affiliated with a social security scheme in France,
AND whose monitoring will be carried out at the recruiting center.
Patient being monitored for a non-urothelial bladder tumor
Patient refusing follow-up
Opposition to participation in the study
Adult protected by law
Association Francaise d'Urologie
Lead sponsor